Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Systemic Carbonic Anhydrase Inhibitors in Common Ophthalmic Diseases: A Scoping Review from A Clinical Standpoint.
Journal: Current ophthalmology reports
Published: April 11, 2025
High altitude renal syndrome: four elements or one source?
Journal: Renal failure
Published: April 03, 2025
Identification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II.
Journal: International journal of biological macromolecules
Published: January 09, 2024
Exploring bioactive compounds from a symbiotic bacterial strain of Spongiobacter sp.
Journal: Bioinformation
Published: April 01, 2023
Pyrazole/pyrazoline as an excellent pharmacophore in the design of carbonic anhydrase inhibitors (2018-2022).
Journal: Archiv der Pharmazie
Published: October 25, 2022
Drug repurposing in skeletal muscle ion channelopathies.
Journal: Current opinion in pharmacology
Published: August 08, 2022
Neuroprotective Effects of Carbonic Anhydrase Inhibition and Cyclic Adenosine Monophosphate Activation in Mouse Model of Transient Global Cerebral Ischemia and Reperfusion.
Journal: Neuromolecular medicine
Published: July 10, 2022
The role of nephrologists in management of hypokalemic periodic paralysis: a case report.
Journal: Journal of medical case reports
Published: September 24, 2021
Dichlorphenamide for Refractory Hyperkalemic Periodic Paralysis.
Journal: Journal of clinical neuromuscular disease
Published: August 25, 2021
Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.
Journal: Neuromuscular disorders : NMD
Published: January 12, 2021
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.
Journal: Journal of neuromuscular diseases
Published: December 16, 2020
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders.
Journal: Experimental neurology
Published: November 02, 2020
Last Updated: 10/31/2025